Organ Preservation Solution Market - By Solution (University of Wisconsin, Custodiol HTK, Perfadex, Celsior), Preservation Type (Static Cold Storage, Hypothermic, Normothermic), Organ (Kidney, Liver, Lungs), End-user, Global Forecast (2023-2032)

List of Tables

Organ Preservation Solution Market size is poised to expand at over 6.8% CAGR from 2023 to 2032, driven by the increasing knowledge of organ donation worldwide.

The growing public awareness campaigns and educational initiatives about the importance of organ donation have led to the rise in voluntary organ donors. With more individuals understanding the impacts of organ transplantation on saving lives, the demand for effective organ preservation solutions is surging. Additionally, leading organizations are emphasizing R&D investments to introduce advanced preservation solutions to enhance organ viability and transplantation success. Several businesses are also planning and implementing strategic initiatives to streamline the organ transplantation process, further contributing to the overall industry growth. For instance, in November 2023, Paragonix Technologies developed a comprehensive network of donor organ procurement, storage, and transportation services.

The organ preservation solution industry is segmented into solution, preservation type, organ, end-user, and region.

As per solution, the market share from the perfadex solution segment is projected to gain significant traction at 6.7% CAGR between 2023 and 2032 owing to its widespread use in lung transplantation procedures. Perfadex solutions boast of unique composition and capabilities in facilitating optimal organ preservation for ensuring extended viability during transplantation. Given their effectiveness in minimizing ischemia-reperfusion injuries and improving post-transplant outcomes, these solutions are increasingly preferred in the organ preservation domain. The increasing number of lung transplants across the globe, driven by the jump in rising respiratory disorders will boost the segment growth.

Based on end-user, the organ preservation solution industry from the hospitals segment witnessed high demand in 2022 and is estimated to record 7.3% growth rate through 2032. Hospitals play a pivotal role in organ transplantation procedures as they necessitate the usage of effective preservation solutions. The increasing number of organ transplants across the globe coupled with the growing emphasis on improving post-transplant outcomes is fueling the demand for high-quality preservation solutions.

Furthermore, the rising investments by hospitals on advanced organ preservation solutions to enhance organ viability, reduce ischemia-reperfusion injuries, and improve the overall transplant success rates will boost the segment growth.

Regionally, the Asia Pacific organ preservation solution market is set to exhibit 7.5% CAGR from 2023 to 2032 owing to the rising prevalence of organ failure and the increasing awareness of transplantation options. Between 2015 and 2022, China reported about 40,200 deceased organ donations, of which 120,100 were major organs. Moreover, the improving healthcare infrastructure along with the surge in government initiatives to enhance organ donation and transplantation programs will propel the regional market expansion.

Product Code: 7564

Chapter 1 Methodology & Scope

1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast calculation
1.4 Covid-19 impact analysis at global level
1.5 Data validation
1.6 Data sources
- 1.6.1 Primary
- 1.6.2 Secondary
  - 1.6.2.1 Paid sources
  - 1.6.2.2 Public sources

Chapter 2 Executive Summary

2.1 Organ preservation solution industry 360 degree synopsis, 2018 - 2032 (USD Million)
- 2.1.1 Business trends
- 2.1.2 Region trends
- 2.1.3 Solution trends
- 2.1.4 Preservation type trends
- 2.1.5 Organ trends
- 2.1.6 End-user trends

Chapter 3 Organ Preservation Solution Market Insights

3.1 Industry landscape, 2018 - 2032 (USD Million)
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing number of organ transplantation procedure
  - 3.2.1.2 Rising healthcare investments
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost of organ transplantation
  - 3.2.2.2 Significant gap between number of organs donated and organs required
3.3 Growth potential analysis
- 3.3.1 By solution
- 3.3.2 By preservation type
- 3.3.3 By organ
- 3.3.4 By end-user
3.4 COVID-19 impact analysis
3.5 Regulatory landscape
3.6 Porter's analysis
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players, 2022
4.4 Competitive positioning matrix, 2022
4.5 Strategic dashboard, 2022

Chapter 5 Organ Preservation Solution Market Estimates and Forecast, By Solution, 2018-2032 (USD Million)

5.1 Key trends, by solution
5.2 University of Wisconsin solution (UW)
5.3 Custodiol HTK solution
5.4 Perfadex solution
5.5 Steen solution
5.6 Celsior solution
5.7 Hypothermosol solution
5.8 Other solutions

Chapter 6 Organ Preservation Solution Market Estimates and Forecast, By Preservation Type, 2018-2032 (USD Million)

6.1 Key trends, by preservation type
6.2 Static cold storage
6.3 Hypothermic machine perfusion
6.4 Normothermic machine perfusion

Chapter 7 Organ Preservation Solution Market Estimates and Forecast, By Organ, 2018-2032 (USD Million)

7.1 Key trends, by organ
7.2 Kidneys
7.3 Liver
7.4 Lungs
7.5 Heart
7.6 Other organs

Chapter 8 Organ Preservation Solution Market Estimates and Forecast, By End-user, 2018-2032 (USD Million)

8.1 Key trends, by end-user
8.2 Organ transplant centers
8.3 Hospitals
8.4 Other end-users

Chapter 9 Organ Preservation Solution Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)

9.1 Key trends, by region
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Rest of Latin America
9.6 Middle East & Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 Rest of Middle East & Africa

Chapter 10 Company Profiles

10.1 Waters Medical Systems LLC
10.2 Xvivo Perfusion AB
10.3 Transmedics, Inc.
10.4 Preservation Solutions, Inc.
10.5 Paragonix Technologies, Inc.
10.6 Organox Limited
10.7 Dr. Franz Koehler Chemie GmbH
10.8 Accord Healthcare Inc.
10.9 21st Century Medicine Inc.
10.10 Shanghai Genext Medical Technology
10.11 Bridge to Life Ltd.
10.12 Transplant Biomedicals